# Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

> **NCT00926068** · PHASE2 · UNKNOWN · sponsor: **HealOr** · enrollment: 196 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** HO/03/03 10µg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00926068
- **Lead sponsor:** HealOr
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2013-08
- **Final completion:** —
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2013-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926068, "Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00926068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*